1,434
Views
42
CrossRef citations to date
0
Altmetric
Review

Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future

, , , , , , , , & show all
Pages 337-362 | Received 05 Dec 2018, Accepted 31 Jan 2019, Published online: 18 Feb 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Rahul Khetan, Robin Curtis, Charlotte M. Deane, Johannes Thorling Hadsund, Uddipan Kar, Konrad Krawczyk, Daisuke Kuroda, Sarah A. Robinson, Pietro Sormanni, Kouhei Tsumoto, Jim Warwicker & Andrew C.R. Martin. (2022) Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics. mAbs 14:1.
Read now
Alexis Q. Dean, Shen Luo, Julianne D. Twomey & Baolin Zhang. (2021) Targeting cancer with antibody-drug conjugates: Promises and challenges. mAbs 13:1.
Read now
Rachel Liuqing Shi, Gang Xiao, Thomas M. Dillon, Margaret S. Ricci & Pavel V. Bondarenko. (2020) Characterization of therapeutic proteins by cation exchange chromatography-mass spectrometry and top-down analysis. mAbs 12:1.
Read now

Articles from other publishers (38)

Igor A. Kaltashov, Daniil G. Ivanov & Yang Yang. (2022) Mass spectrometry‐based methods to characterize highly heterogeneous biopharmaceuticals, vaccines, and nonbiological complex drugs at the intact‐mass level. Mass Spectrometry Reviews 43:1, pages 139-165.
Crossref
Corentin Beaumal, Evolène Deslignière, Hélène Diemer, Christine Carapito, Sarah Cianférani & Oscar Hernandez-Alba. (2023) Improved characterization of trastuzumab deruxtecan with PTCR and internal fragments implemented in middle-down MS workflows. Analytical and Bioanalytical Chemistry.
Crossref
Natsuki Shikida, Shunsuke Yamazaki, Kazutoshi Takahashi, Yutaka Matsuda & Kazutaka Shimbo. (2023) Analytical studies on the conjugation site specificity of trastuzumab modified by Escherichia coli lipoate ligase A: multiple-enzyme digestion approach for peptide mapping. Analytical and Bioanalytical Chemistry.
Crossref
Charles Dumontet, Janice M. Reichert, Peter D. Senter, John M. Lambert & Alain Beck. (2023) Antibody–drug conjugates come of age in oncology. Nature Reviews Drug Discovery 22:8, pages 641-661.
Crossref
Tinglin Yang, Wenhui Li, Tao Huang & Jun Zhou. (2023) Antibody-Drug Conjugates for Breast Cancer Treatment: Emerging Agents, Targets and Future Directions. International Journal of Molecular Sciences 24:15, pages 11903.
Crossref
Wayne Yu, Mysore P. Ramprasad, Manoj Pal, Chris Chen, Shashi Paruchuri, Lillian Skidmore, Nick Knudsen, Molly Allen & Ying Buechler. (2023) Analytical comparability to evaluate impact of manufacturing changes of ARX788, an Anti-HER2 ADC in late-stage clinical development. PLOS ONE 18:7, pages e0284198.
Crossref
Tessa Reinert, Pascal Houzé, Nathalie Mignet, Yannis-Nicolas Francois & Rabah Gahoual. (2023) Post-translational modifications comparative identification and kinetic study of infliximab innovator and biosimilars in serum using capillary electrophoresis-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, pages 115541.
Crossref
Ritwik Maiti, Bhumika Patel, Nrupesh Patel, Mehul Patel, Alkesh Patel & Nirav Dhanesha. (2023) Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities. Archives of Pharmacal Research 46:5, pages 361-388.
Crossref
Balázs Bobály. 2023. Liquid Chromatography. Liquid Chromatography 891 911 .
Pauline Legrand, Sophie Dufaÿ, Nathalie Mignet, Pascal Houzé & Rabah Gahoual. (2022) Modeling study of long-term stability of the monoclonal antibody infliximab and biosimilars using liquid-chromatography–tandem mass spectrometry and size-exclusion chromatography–multi-angle light scattering. Analytical and Bioanalytical Chemistry 415:1, pages 179-192.
Crossref
Tessa Reinert, Alain Beck, Pascal Houzé, Rabah Gahoual & Yannis Francois. 2022. Capillary Electrophoresis‐Mass Spectrometry for Proteomics and Metabolomics. Capillary Electrophoresis‐Mass Spectrometry for Proteomics and Metabolomics 281 312 .
Neh Nupur & Anurag S. Rathore. (2022) Elucidating chemical and disulfide heterogeneities in rituximab using reduced and non‐reduced peptide mapping. Journal of Separation Science 45:15, pages 2887-2900.
Crossref
Soraya Chapel, Florent Rouvière, Pierre Guibal, Delphine Mathieu & Sabine Heinisch. (2022) Development of a sub-hour on-line comprehensive cation exchange chromatography x RPLC method hyphenated to HRMS for the characterization of lysine-linked antibody-drug conjugates. Talanta 240, pages 123174.
Crossref
Szabolcs Fekete, Mathew DeLano, Andrew Bates Harrison, Stephen J. Shiner, Jonathan Leon Belanger, Kevin D. Wyndham & Matthew A. Lauber. (2022) Size Exclusion and Ion Exchange Chromatographic Hardware Modified with a Hydrophilic Hybrid Surface. Analytical Chemistry 94:7, pages 3360-3367.
Crossref
Yiming Jin, Megan A. Schladetsch, Xueting Huang, Marcy J. Balunas & Andrew J. Wiemer. (2022) Stepping forward in antibody-drug conjugate development. Pharmacology & Therapeutics 229, pages 107917.
Crossref
Alan Kadek, Kristina Lorenzen & Charlotte Uetrecht. (2021) In a flash of light: X-ray free electron lasers meet native mass spectrometry. Drug Discovery Today: Technologies 39, pages 89-99.
Crossref
Yutaka MatsudaBrian A. Mendelsohn. (2021) Recent Advances in Drug–Antibody Ratio Determination of Antibody–Drug Conjugates. Chemical and Pharmaceutical Bulletin 69:10, pages 976-983.
Crossref
Szabolcs Fekete, Valentina D'Atri & Davy Guillarme. 2021. Optimization in HPLC. Optimization in HPLC 57 71 .
Yutaka Matsuda, Monica Leung, Zhala Tawfiq, Tomohiro Fujii & Brian A. Mendelsohn. (2021) In-situ Reverse Phased HPLC Analysis of Intact Antibody-Drug Conjugates. Analytical Sciences 37:8, pages 1171-1176.
Crossref
Armelle Martelet, Valerie Garrigue, Zoe Zhang, Bruno Genet & Andras Guttman. (2021) Multi-attribute method based characterization of antibody drug conjugates (ADC) at the intact and subunit levels. Journal of Pharmaceutical and Biomedical Analysis 201, pages 114094.
Crossref
Calvin D. Lewis, Abhay K. Singh, Fong-Fu Hsu, Dinesh Thotala, Dennis E. Hallahan & Vaishali Kapoor. (2021) Targeting a Radiosensitizing Antibody–Drug Conjugate to a Radiation-Inducible Antigen. Clinical Cancer Research 27:11, pages 3224-3233.
Crossref
Angel Puerta, Laura Gomez-Ruiz, Jose C. Diez-Masa & Mercedes de Frutos. 2021. Carbohydrate Analysis by Modern Liquid Phase Separation Techniques. Carbohydrate Analysis by Modern Liquid Phase Separation Techniques 645 727 .
Elsa Wagner-Rousset, Olivier Colas, Stéphane Chenu, Yannis-Nicolas François, Davy Guillarme, Sarah Cianferani, Yury O. Tsybin, Jonathan Sjögren, Arnaud Delobel & Alain Beck. 2021. Mass Spectrometry of Glycoproteins. Mass Spectrometry of Glycoproteins 73 83 .
Nicolas Joubert, Alain Beck, Charles Dumontet & Caroline Denevault-Sabourin. (2020) Antibody–Drug Conjugates: The Last Decade. Pharmaceuticals 13:9, pages 245.
Crossref
Kristina Srzentić, Luca Fornelli, Yury O. Tsybin, Joseph A. Loo, Henrique Seckler, Jeffrey N. Agar, Lissa C. Anderson, Dina L. Bai, Alain Beck, Jennifer S. Brodbelt, Yuri E. M. van der Burgt, Julia Chamot-Rooke, Sneha Chatterjee, Yunqiu Chen, David J. Clarke, Paul O. Danis, Jolene K. Diedrich, Robert A. D’Ippolito, Mathieu Dupré, Natalia Gasilova, Ying Ge, Young Ah Goo, David R. Goodlett, Sylvester Greer, Kim F. Haselmann, Lidong He, Christopher L. Hendrickson, Joshua D. Hinkle, Matthew V. Holt, Sam Hughes, Donald F. Hunt, Neil L. Kelleher, Anton N. Kozhinov, Ziqing Lin, Christian Malosse, Alan G. Marshall, Laure Menin, Robert J. Millikin, Konstantin O. Nagornov, Simone Nicolardi, Ljiljana Paša-Tolić, Stuart Pengelley, Neil R. Quebbemann, Anja Resemann, Wendy Sandoval, Richa Sarin, Nicholas D. Schmitt, Jeffrey Shabanowitz, Jared B. Shaw, Michael R. Shortreed, Lloyd M. Smith, Frank Sobott, Detlev Suckau, Timothy Toby, Chad R. Weisbrod, Norelle C. Wildburger, John R. YatesIIIIII, Sung Hwan Yoon, Nicolas L. Young & Mowei Zhou. (2020) Interlaboratory Study for Characterizing Monoclonal Antibodies by Top-Down and Middle-Down Mass Spectrometry. Journal of the American Society for Mass Spectrometry 31:9, pages 1783-1802.
Crossref
Eleanor Watts, Jon D. Williams, Laura J. Miesbauer, Milan Bruncko & Jennifer S. Brodbelt. (2020) Comprehensive Middle-Down Mass Spectrometry Characterization of an Antibody–Drug Conjugate by Combined Ion Activation Methods. Analytical Chemistry 92:14, pages 9790-9798.
Crossref
Zhala Tawfiq, Yutaka Matsuda, Melody Jane Alfonso, Colin Clancy, Veronica Robles, Monica Leung & Brian A. Mendelsohn. (2020) Analytical Comparison of Antibody-drug Conjugates Based on Good Manufacturing Practice Strategies. Analytical Sciences 36:7, pages 871-875.
Crossref
Bastiaan L. Duivelshof, Evolène Deslignière, Oscar Hernandez-Alba, Anthony Ehkirch, Hanna Toftevall, Jonathan Sjögren, Sarah Cianferani, Alain Beck, Davy Guillarme & Valentina D’Atri. (2020) Glycan-Mediated Technology for Obtaining Homogeneous Site-Specific Conjugated Antibody–Drug Conjugates: Synthesis and Analytical Characterization by Using Complementary Middle-up LC/HRMS Analysis. Analytical Chemistry 92:12, pages 8170-8177.
Crossref
Rabah Gahoual, Gérard Bolbach, Ikram Ould-Melha, Gilles Clodic, Yannis-Nicolas François, Daniel Scherman, Nathalie Mignet & Pascal Houzé. (2020) Kinetic and structural characterization of therapeutic albumin chemical functionalization using complementary mass spectrometry techniques. Journal of Pharmaceutical and Biomedical Analysis 185, pages 113242.
Crossref
Igor Dovgan, Anthony Ehkirch, Victor Lehot, Isabelle Kuhn, Oleksandr Koniev, Sergii Kolodych, Alexandre Hentz, Manon Ripoll, Sylvain Ursuegui, Marc Nothisen, Sarah Cianférani & Alain Wagner. (2020) On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency. Scientific Reports 10:1.
Crossref
Yutaka Matsuda, Maria-Christina Malinao, Veronica Robles, James Song, Kei Yamada & Brian A. Mendelsohn. (2020) Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation. Journal of Chromatography B 1140, pages 121981.
Crossref
Hae-Min Park, Valerie J. Winton, Jared J. Drader, Sheri Manalili Wheeler, Greg A. Lazar, Neil L. Kelleher, Yichin Liu, John C. Tran & Philip D. Compton. (2019) Novel Interface for High-Throughput Analysis of Biotherapeutics by Electrospray Mass Spectrometry. Analytical Chemistry 92:2, pages 2186-2193.
Crossref
Donmienne Leung, Jacqueline Wurst, Tao Liu, Ruben Martinez, Amita Datta-Mannan & Yiqing Feng. (2020) Antibody Conjugates-Recent Advances and Future Innovations. Antibodies 9:1, pages 2.
Crossref
Anna C. Robotham & John F. Kelly. 2020. Approaches to the Purification, Analysis and Characterization of Antibody-Based Therapeutics. Approaches to the Purification, Analysis and Characterization of Antibody-Based Therapeutics 1 33 .
Oscar Hernandez-Alba, Anthony Ehkirch, Alain Beck & Sarah Cianférani. 2020. Antibody-Drug Conjugates. Antibody-Drug Conjugates 197 211 .
Elsa Wagner-Rousset, Olivier Colas, Yannis-Nicolas François, Sabine Heinisch, Davy Guillarme, Sarah Cianférani & Alain Beck. 2020. Antibody-Drug Conjugates. Antibody-Drug Conjugates 187 195 .
J. Delahousse, C. Skarbek & A. Paci. (2019) Prodrugs as drug delivery system in oncology. Cancer Chemotherapy and Pharmacology 84:5, pages 937-958.
Crossref
Antony Lechner, Jérémie Giorgetti, Rabah Gahoual, Alain Beck, Emmanuelle Leize-Wagner & Yannis-Nicolas François. (2019) Insights from capillary electrophoresis approaches for characterization of monoclonal antibodies and antibody drug conjugates in the period 2016–2018. Journal of Chromatography B 1122-1123, pages 1-17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.